[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 74, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2024, "totalPay": 748600, "exercisedValue": 0, "unexercisedValue": 809000}, {"maxAge": 1, "name": "Mr. Mark Patrick Guerin C.M.A., CPA, CFM", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen M.B.A.", "title": "Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.43, "open": 2.46, "dayLow": 2.365, "dayHigh": 2.55, "regularMarketPreviousClose": 2.43, "regularMarketOpen": 2.46, "regularMarketDayLow": 2.365, "regularMarketDayHigh": 2.55, "payoutRatio": 0.0, "beta": 1.313, "forwardPE": -2.0789473, "volume": 216558, "regularMarketVolume": 216558, "averageVolume": 1672383, "averageVolume10days": 371690, "averageDailyVolume10Day": 371690, "bid": 2.37, "ask": 2.38, "bidSize": 1300, "askSize": 300, "marketCap": 62811840, "fiftyTwoWeekLow": 1.11, "fiftyTwoWeekHigh": 5.5, "allTimeHigh": 132.0, "allTimeLow": 1.11, "fiftyDayAverage": 3.4084, "twoHundredDayAverage": 2.67985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 47525448, "profitMargins": 0.0, "floatShares": 22408193, "sharesOutstanding": 26502889, "sharesShort": 2935736, "sharesShortPriorMonth": 3044065, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1108, "heldPercentInsiders": 0.1545, "heldPercentInstitutions": 0.18406999, "shortRatio": 5.49, "shortPercentOfFloat": 0.1238, "impliedSharesOutstanding": 26502889, "bookValue": 0.652, "priceToBook": 3.634969, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -24884444, "trailingEps": -1.43, "forwardEps": -1.14, "52WeekChange": -0.020161271, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 2.37, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 13.75, "targetMedianPrice": 13.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 15286399, "totalCashPerShare": 0.577, "totalDebt": 0, "quickRatio": 4.094, "currentRatio": 4.604, "returnOnAssets": -1.05878, "returnOnEquity": -2.46139, "freeCashflow": -15614118, "operatingCashflow": -24978014, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.43, "epsForward": -1.14, "epsCurrentYear": -1.29, "priceEpsCurrentYear": -1.8372092, "fiftyDayAverageChange": -1.0384002, "fiftyDayAverageChangePercent": -0.30465913, "twoHundredDayAverageChange": -0.30985022, "twoHundredDayAverageChangePercent": -0.11562222, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580308200000, "postMarketChangePercent": -0.42194054, "postMarketPrice": 2.36, "postMarketChange": -0.00999999, "regularMarketChange": -0.0600002, "regularMarketDayRange": "2.365 - 2.55", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 1672383, "fiftyTwoWeekLowChange": 1.2599999, "fiftyTwoWeekLowChangePercent": 1.135135, "fiftyTwoWeekRange": "1.11 - 5.5", "fiftyTwoWeekHighChange": -3.13, "fiftyTwoWeekHighChangePercent": -0.5690909, "fiftyTwoWeekChangePercent": -2.016127, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1771025041, "regularMarketTime": 1771016402, "exchange": "NYQ", "messageBoardId": "finmb_622711087", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.46914, "regularMarketPrice": 2.37, "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "displayName": "Annovis Bio", "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]